What does it take for a country to develop and build a truly innovative pharmaceutical sector, especially when it comes to emerging markets? Although there has been tremendous overall economic growth in recent decades, why is there yet no world-class innovation hub in these geographies? And how is it that some places in the world are able to foster innovation, while others fail in spite of strong efforts? Are there certain key elements that are critical? In Drugs, Politics, and Innovation, author Ajay Gautam presents a new paradigm for understanding the healthcare ecosystems in markets and in countries likely to emerge as future innovation leaders. Using case studies and the author's own experiences from various emerging markets such as China, India, Russia, Brazil, Egypt, Saudi Arabia, the Uae, Mexico, as well as Israel and the United States, it evaluates and contrasts the approaches key countries are taking, and it forecasts what the future may hold for such efforts with respect to the life sciences, biotech, and pharmaceutical industries. Using the Vital model-built on critical elements like venture capital and funding, research and design infrastructure, a talent pool, leading universities and academia, and government policies, incentives, and legislation-can help provide a framework for creating a sustainable, optimal, and productive innovation ecosystem.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Chiron Media, Wallingford, Vereinigtes Königreich
PF. Zustand: New. This item is printed on demand. Brand new book, sourced directly from publisher. Dispatch time is 6-7 days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely. Bestandsnummer des Verkäufers 6666-IUK-9781482864151
Anzahl: 20 verfügbar
Anbieter: Rarewaves.com USA, London, LONDO, Vereinigtes Königreich
Paperback. Zustand: New. Bestandsnummer des Verkäufers LU-9781482864151
Anzahl: Mehr als 20 verfügbar
Anbieter: California Books, Miami, FL, USA
Zustand: New. Bestandsnummer des Verkäufers I-9781482864151
Anzahl: Mehr als 20 verfügbar
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In English. Bestandsnummer des Verkäufers ria9781482864151_new
Anzahl: Mehr als 20 verfügbar
Anbieter: THE SAINT BOOKSTORE, Southport, Vereinigtes Königreich
Paperback / softback. Zustand: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days. Bestandsnummer des Verkäufers C9781482864151
Anzahl: Mehr als 20 verfügbar
Anbieter: Books Puddle, Woodside, NY, USA
Zustand: New. Bestandsnummer des Verkäufers 26376415322
Anzahl: 1 verfügbar
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. Bestandsnummer des Verkäufers 370678661
Anzahl: 1 verfügbar
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New. PRINT ON DEMAND. Bestandsnummer des Verkäufers 18376415312
Anzahl: 4 verfügbar
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - What does it take for a country to develop and build a truly innovative pharmaceutical sector, especially when it comes to emerging markets Although there has been tremendous overall economic growth in recent decades, why is there yet no world-class innovation hub in these geographies And how is it that some places in the world are able to foster innovation, while others fail in spite of strong efforts Are there certain key elements that are critical In Drugs, Politics, and Innovation, author Ajay Gautam presents a new paradigm for understanding the healthcare ecosystems in markets and in countries likely to emerge as future innovation leaders. Using case studies and the author's own experiences from various emerging markets such as China, India, Russia, Brazil, Egypt, Saudi Arabia, the UAE, Mexico, as well as Israel and the United States, it evaluates and contrasts the approaches key countries are taking, and it forecasts what the future may hold for such efforts with respect to the life sciences, biotech, and pharmaceutical industries. Using the VITAL model-built on critical elements like venture capital and funding, research and design infrastructure, a talent pool, leading universities and academia, and government policies, incentives, and legislation-can help provide a framework for creating a sustainable, optimal, and productive innovation ecosystem. Bestandsnummer des Verkäufers 9781482864151
Anzahl: 1 verfügbar
Anbieter: moluna, Greven, Deutschland
Kartoniert / Broschiert. Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. KlappentextrnrnWhat does it take for a country to develop and build a truly innovative pharmaceutical sector, especially when it comes to emerging markets? Although there has been tremendous overall economic growth in recent decades, why is ther. Bestandsnummer des Verkäufers 447914340
Anzahl: Mehr als 20 verfügbar